Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) Revenue growth

Elevance Health, Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.29%, down 6.2 percentage points from fiscal 2025 (12.5%). Over the past ten years it has ranged from 2.29% (fiscal 2018) to 16.9% (fiscal 2020); the current reading is higher than 64% of that period. That is below the Healthcare Plans industry median of 7.57% and below the Healthcare sector median of 8.26%.

Revenue growth, annual

Annual

Period Revenue growth Change (points)
FY2025 12.5% 9.18
FY2024 3.31% (6.11)
FY2023 9.42% (3.53)
FY2022 13.0% (0.81)
FY2021 13.8% (3.18)
FY2020 16.9% 3.79
FY2019 13.2% 10.86
FY2018 2.29% (3.81)
FY2017 6.10% (1.11)
FY2016 7.21% 0.06

Quarterly

Period Revenue growth Change (points)
Jun 2026 1.40% (1.24)
Mar 2026 2.64% (6.83)
Dec 2025 9.47% (2.96)
Sep 2025 12.4% (0.99)
42 more quarters

Against its own ten years

Low 2.29% High 16.9%
Ten-year median 9.42%
Current reading's percentile 64

Revenue growth against peers

Company Revenue growth
CLOV Clover Health Investments, Corp. compare 54.0%
OSCR Oscar Health, Inc. compare 42.8%
HUM Humana Inc. compare 18.3%
CNC Centene Corporation compare 13.9%
CI Cigna Group compare 7.77%
CVS CVS Health Corporation compare 7.36%
UNH UnitedHealth Group Incorporated compare 6.46%
ELV Elevance Health, Inc. 6.29%
MOH Molina Healthcare, Inc compare 2.55%
Healthcare Plans industry median 7.57%
Healthcare sector median 8.26%
Market median 7.41%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on ELV